3.0.0 2493 2023-01-11T13:40:01Z 2023-01-11T13:40:01Z Senate S 2018-03-05 115 ssju00 Judiciary Committee Senate Standing Referred to 2018-03-05T23:00:43Z DEA Enforcement and Authority Act of 2018 115 6702 HR 2018-10-09 Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations. Related bill CRS 2018-03-05 ssju00 Judiciary Committee Senate Read twice and referred to the Committee on the Judiciary. IntroReferral 2018-03-05 Introduced in Senate IntroReferral 10000 9 Library of Congress M001183 Sen. Manchin, Joe, III [D-WV] Joseph Manchin D WV N Crime and Law Enforcement Administrative remedies Department of Justice Drug Enforcement Administration (DEA) Drug trafficking and controlled substances Licensing and registrations Crime and Law Enforcement 00 2018-03-05 Introduced in Senate 2019-03-28T21:24:56Z DEA Enforcement and Authority Act of 2018

This bill amends the Controlled Substances Act (CSA) to modify enforcement authorities of the Drug Enforcement Administration (DEA).

The bill modifies the required elements of an order to show cause issued by the DEA before it denies, revokes, or suspends a registration for a CSA violation. Specifically, it eliminates the requirement for an order to show cause to notify the registrant of the opportunity to submit a corrective action plan.

Additionally, the bill modifies the standard of review for an immediate suspension order. Currently, the DEA may immediately suspend the registration of a controlled substances manufacturer, distributor, or dispenser to prevent imminent danger to the public health and safety. This bill lowers the standard for determining imminent danger to the public health and safety—from substantial likelihood of an immediate threat of harm to probable cause that harm will occur.

]]> DEA Enforcement and Authority Act of 2018 Display Title DEA Enforcement and Authority Act of 2018 Official Title as Introduced A bill to clarify the congressional intent behind the requirements relating to immediate suspension orders and corrective action plans under the Controlled Substances Act that were added by the Ensuring Patient Access and Effective Drug Enforcement Act of 2016. Introduced in Senate IS Short Titles as Introduced DEA Enforcement and Authority Act of 2018 Introduced in Senate 2018-03-05T05:00:00Z https://www.govinfo.gov/content/pkg/BILLS-115s2493is/xml/BILLS-115s2493is.xml 2018-03-05 Read twice and referred to the Committee on the Judiciary. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.